UNSPSC 51284047: Tetracycline trihydrate

This classification denotes a tetracycline antibiotic C22H24N2O8.3H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 93V6NC52SB, chemically known as 2-naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, hydrate (1:3), (4s,4as,5as,6s,12as)-, but more generally known as tetracycline trihydrate, which bears US NIH Compound Identifier 67858637. Most nations, for tariff and trade purposes, schedule tetracycline trihydrate under HS 29413000 and SITC 54133.

As of Q4 2014, TETRACYCLINE TRIHYDRATE remains US FDA's Preferred Term for this commodity. SMILES: C[C@]1(C2CCCC(C2C(=O)C3=C([C@]4([C@@H](C[C@@H]31)[C@@H](C(=C(C4=O)C(=O)N)O)N(C)C)O)O)O)O.O.O.O.

UNSPSC 51284047 Tetracycline trihydrate is a Commodity code that nominally names a specific pharmaceutical ingredient, but recent state and local procurement activity under this code shows little to no alignment with the abstract scope — the recent opportunities tagged to it involve naloxone and drug deactivation systems, direct-to-manufacturer prescription programs, emergency medical and first-aid supplies for fire rescue operations, and generic multi-source pharmaceuticals and OTC products distributed through established wholesalers. The mismatch between the code's nominal scope and the actual work being solicited suggests either a tagging error in the underlying procurement system or a significant drift in how the code is applied in practice. State and local issuing bodies posting under this code include county health departments (Seminole County, Florida), state health and human services agencies (Texas HHS Commission), municipal purchasing offices (City of Tampa), and multi-state cooperative purchasing alliances (Minnesota MMCAP).

Geographic activity centers on Florida, Texas, Minnesota, and Oregon, with the recent opportunities spanning a range of issuing-body types and procurement vehicles. Representative recent solicitations include Seminole County's IFB for naloxone and drug deactivation systems (1,900 units of naloxone and 800 systems annually, due July 26, 2026), the City of Tampa's ITB for medical and first-aid supplies for the Fire Department Rescue Division (169 line items, estimated contract value $700,000, due March 13, 2026), and the Minnesota MMCAP's RFP for generic multi-source pharmaceuticals and OTC products across state and local government facilities (proposals due March 26, 2026). The Texas HHS Commission also issued an RFI on direct-to-manufacturer prescription programs (April 3, 2026) as a market intelligence vehicle ahead of a formal RFP. The code's recent activity reflects procurement of pharmaceuticals, emergency medical supplies, and health-related consumables rather than the tetracycline trihydrate specifically named in the code descriptor, making this code potentially misapplied or overbroad in current state and local practice.